Skip to main content

FOCUS-Pfizer, Novartis lead $2 bln spending spree on gene therapy production

* FDA focusing on manufacturing consistency - executives (Adds $2 bln figure in headline)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.